Skip to main content

What the label lists and what reports show

Nitric oxide side effects

Nitric oxide's FDA label: “The most common adverse reaction is hypotension ( 6 ).” FAERS holds 4,473 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is device malfunction (636 reports).

  • Generic listed

Check it at the source: the nitric oxide FDA label on DailyMed (effective December 11, 2025, VERO BIOTECH, INC.); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

The most common adverse reaction is hypotension ( 6 ).

From the label: adverse reactions, continued

The following adverse reactions are discussed elsewhere in the label; Hypoxemia [see Warnings and Precautions (5.2) ] Worsening Heart Failure [see Warnings and Precautions (5.4) ] The most common adverse reaction is hypotension ( 6 ). To report SUSPECTED ADVERSE REACTIONS, contact Vero Biotech at 1-877-337-4118 and http://www.vero-biotech.com/ or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The adverse reaction information from the clinical studies does, however, provide a basis for identifying the adverse events that appear to be related to drug use and for approximating rates. Controlled studies have included 325 patients on nitric oxide doses of 5 to 80 ppm and 251 patients on placebo. Total mortality in the pooled trials was 11% on placebo and 9% on nitric oxide gas for inhalation, a result adequate to exclude nitric oxide mortality being more than 40% worse than placebo. In both the NINOS and CINRGI studies, the duration of hospitalization was similar in nitric oxide gas for inhalation and placebo-treated groups. …

Source: FDA drug label, VERO BIOTECH, INC., effective December 11, 2025 (SPL set c9560c54-9e28-4039-a4e5-5000c41c6c85), via openFDA; the full label on DailyMed

What do FAERS reports show?

4,473 reports list nitric oxide among the medicines taken, each a report of something that happened, not proof the medicine caused it; 1,320 are coded as a death and 712 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 14 reactions below, 4 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • No Adverse Event (a use or a product term, not a reaction)789
  • Device Malfunction636
  • Device Issue452
  • Underdose (a use or a product term, not a reaction)444
  • Death (an outcome recorded in the report)383
  • Product Use Issue (a use or a product term, not a reaction)368
  • Off Label Use (a use or a product term, not a reaction)339
  • Drug Ineffective (a use or a product term, not a reaction)325
  • Oxygen Saturation Decreased270
  • Product Use In Unapproved Indication (a use or a product term, not a reaction)208
  • Condition Aggravated (a use or a product term, not a reaction)186
  • Pulmonary Hypertension (a use or a product term, not a reaction)151
  • Device Failure147
  • Respiratory Failure (a use or a product term, not a reaction)144
  • Hypotension (named in the label)140
  • Hypoxia132
  • Device Delivery System Issue122
  • Cardiac Arrest (named in the label)117
  • Drug Ineffective For Unapproved Indication (a use or a product term, not a reaction)84
  • Pulmonary Haemorrhage (named in the label)82
  • Therapy Non-Responder76
  • Multiple Organ Dysfunction Syndrome73
  • Cardio-Respiratory Arrest71
  • Pulmonary Oedema (named in the label)71
  • Premature Baby70

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Nitric oxide: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions